Review article on nanoemulsions and nanostructured lipid carriers | ||
| Records of Pharmaceutical and Biomedical Sciences | ||
| Article 3, Volume 2, Issue 2, September 2018, Pages 23-31 PDF (421.11 K) | ||
| Document Type: Mini-reviews | ||
| DOI: 10.21608/rpbs.2018.5223.1011 | ||
| Authors | ||
| samar hamed faheim* 1; ahmed refaat gardouh2; ahmed talaat nouh3; mamdouh mostafa ghorab4 | ||
| 1pharmaceutics department, faculty of pharmacy, horus university, new damietta | ||
| 2pharmaceutics department, faculty of pharmacy, suez canal university | ||
| 3pharmaceutics department, faculty of pharmacy, delta university,gamasa,egypt | ||
| 4pharmaceutics, faculty of pharmacy, suez canal university,egypt | ||
| Abstract | ||
| Lipid nanoparticles, including nanoemulsions (NEs) and nanostructured lipid carriers (NLCs) are colloidal carriers with a lipid matrix that is solid at body temperature. These colloidal carriers have attracted increasing interest for their use in therapeutic and cosmetic applications. The performance of lipid nanoparticle formulations is greatly influenced by their composition and structure. Lipid nanoparticles are generally composed of lipids, surfactants and co-surfactants. The lipid materials used in the production of lipid nanoparticles are usually solid at room temperature. Being well-tolerated in physiological conditions, lipid nanoparticles are typically biocompatible. Liquid lipids, or oils, are specifically used for production of NLCs. In most cases, lipid nanoparticles are produced as dispersions and surface-tailored with surfactants to improve dispersion stability. It was shown that NLCs reveal some advantages for drug therapy over conventional carriers, including increased solubility, the ability to enhance storage stability, improved permeability and bioavailability, reduced adverse effect, prolonged half-life, and tissue-targeted delivery. | ||
| Keywords | ||
| Nanotechnology; Nanoemulsion; nanostructured lipid carrier | ||
|
Statistics Article View: 473 PDF Download: 685 |
||
